Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI-Reference-Cited by-同舟云学术

Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI

Published:2020-05 Issue:5 Volume:20 Page:267-271
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Petrova Anna^ORCID,Chelysheva Ekaterina,Shukhov Oleg^ORCID,Bykova Anastasiya^ORCID,Nemchenko Irina,Gusarova Galina,Tsyba Nikolay,Julhakyan Hunan^ORCID,Shuvaev Vasiliy,Fominykh Mikhail^ORCID,Martynkevich Irina,Ionova Tatyana,Turkina Anna

Funder

BMS

Takeda

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials;Sasaki;Lancet Haematol,2015

2. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population;Bower;J Clin Oncol,2016

3. Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors;Sasaki;Cancer,2016

4. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial;Mahon;Lancet Oncol,2010

5. Long-term follow-up of the French Stop Imatinib (STIM1) study in patients with chronic myeloid leukemia;Etienne;J Clin Oncol,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Level of CD8+PD-1+ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation;Cells;2024-04-22

2. 25 years of experience in the treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: results, opportunities, questions;Meditsinskiy sovet = Medical Council;2024-01-17

3. Exploration of treatment‐free remission in CML, based on molecular monitoring;Cancer Medicine;2023-12-22

4. Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives;European Journal of Oncology Nursing;2023-12

5. Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia;Terapevticheskii arkhiv;2022-08-12